InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,034.46
(
0.32%
)
US TECH 100
16,879.60
(
0.11%
)
Dow Jones
38,053.65
(
0.40%
)
Brent Oil
83.60
(
0.07%
)
Bitcoin
58,799.58
(
0.96%
)
Post# of 251673
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

goochbart

Send PM Follow Ignore
Followers 0
Posts 45
Boards Moderated 0
Alias Born 01/30/2012

goochbart

Re: None

Wednesday, 06/28/2017 12:43:35 PM

Wednesday, June 28, 2017 12:43:35 PM

Post# of 251673


AVEO Does AVEO remind anyone of EXEL? AVEO has had redemption with Tivinabid. The drug is ready for approval in EU for possible first line renal cancer. Low toxicity profile and use in combination could be a big disrupter in space. Appears really undervalued with near term catalysts. Any additional viewpoints desired?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up